# FOSAPREPITANT DIMEGLUMINE
> **ANDA212957** · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2020-08-20
## Drug
- **FDA Application Number:** ANDA212957
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FOSAPREPITANT DIMEGLUMINE
- **Generic name:** Fosaprepitant Dimeglumine
- **Active ingredients:** FOSAPREPITANT DIMEGLUMINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** NAVINTA LLC
- **First approval:** 2020-08-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212957)
---
*MORVS · CC0 1.0*